The Usefulness of Tc-99m Tetrofosmin Scintigraphy in the Diagnosis and Localization of Hyperfunctioning Parathyroid Glands
- 1 December 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 24 (12) , 959-64
- https://doi.org/10.1097/00003072-199912000-00011
Abstract
The aim of the work was to study the diagnostic value of Tc-99m tetrofosmin to localize anomalous parathyroid glands in patients with hyperparathyroid disease. We studied 31 patients, 19 with primary and 12 with secondary hyperparathyroid disease. Five of these patients were renal graft recipients. All patients underwent surgery. Each patient was injected with 555 to 740 MBq (15 to 20 mCi) Tc-99m tetrofosmin. Subsequently, radionuclide images were acquired 15 and 120 minutes after injection using a low-energy, all-purpose, parallel-hole collimator. Pertechnetate thyroid scintigraphy was obtained in nine cases (24 to 48 h later) when the thyroid activity made it difficult to identify the parathyroid glands. All cases showed tracer uptake as early as 15 minutes after injection. In the group of patients with primary hyperparathyroid disease, 15 showed focal uptake in a parathyroid gland, and surgery revealed an adenoma in the same location. In one patient with hyperplasia, scintigraphy identified only two of four diseased glands. In the three remaining cases, scintigraphy showed focal uptake in the lower parathyroid gland, whereas at surgery the abnormal gland was located in the upper pole. In the secondary hyperparathyroidism group, seven patients showed diffuse tracer uptake in two or more glands, and histologic analysis confirmed hyperplasia in all of them. Five cases showed focal uptake, with three evaluated after surgery (uptake in the only remaining gland); one of them was a renal graft recipient, and the remaining patient had chronic renal failure and was receiving hemodialysis. Our results suggest that Tc-99m tetrofosmin may be a suitable tracer for preoperative detection and screening of anomalous parathyroid glands. The earlier images at 15 minutes were better than those at 120 minutes. Tc-99m tetrofosmin is cleared more slowly from the normal thyroid than is Tc-99m sestamibi, and both of these tracers may give better results than the old pertechnetate Tl-201 subtraction technique.Keywords
This publication has 9 references indexed in Scilit:
- Parathyroid imaging with 99Tcm-tetrofosminNuclear Medicine Communications, 1996
- Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Sestamibi parathyroid imagingSeminars in Nuclear Medicine, 1995
- Parathyroid imagingNuclear Medicine Communications, 1995
- A New Approach to ParathyroidectomyAnnals of Surgery, 1994
- Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Parathyroid imaging by Tc/TI scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- 99Tcm sestamibi — a new agent for parathyroid imagingNuclear Medicine Communications, 1989